Frank Curzio
By Frank CurzioJanuary 30, 2017

Ep. 486: Frankly Speaking: How to invest on my recommendations

Welcome back to another episode…To start off today’s stream of questions, I explain to listeners one of the biggest misconceptions in investing.The key to investing in any stock (not just the ones I recommend) comes down to just one simple trick – patience. Many listeners have learned the hard way so I wanted to fully address this once and for all.Its extremely important that investors take their time on placing their bets. Meaning, if you do believe in a stock’s long-term position, don’t make a FULL investment all on the same day.Tune in as I explain how this strategy is one of the best ways to avoid volatility in the markets. I guarantee your returns will see better results.I then revisit my position on a stock that’s been beaten down tremendously. This stock was considered “the darling” of the biotech industry a little over a year ago. It went from being loved by analysts across the board, to now – hated.I’ll be explaining why this biotech pioneer has the potential to rebound over the next 12 to 18 months.Moving on to the next question, I talk about one of today’s biggest trends – Marijuana. David, a Colorado local, says the marijuana industry is booming and asks if now is the perfect time to invest…I couldn’t disagree anymore.If you own any marijuana stocks, be sure to listen as I break down the sector. Although we’ve seen a recent run-up in stock prices, I believe the industry will continue to face huge headwinds. These stocks are simply trades… NOT investments.And finally, to end the episode, it’s Nike (NKE) vs. Under Armour (UA). Tune in as I pick my favorite out of the two for 2017.Other topics include: A sneak peek for next week’s Wall Street Unplugged with CEO of Blackbird Energy (BBI.V), KKR‘s future earnings, and whether it’s too late to get in on Northern Dynasty (NAK).Special thanks to Roland, Brandon, Matt, David, Dave, Nate, and Steve.Keep the questions coming!

Links & Resources

Other Stocks mentioned

  • Bristol-Myers Squibb Company (BMY)
  • Merck & Co (MRK)
  • Roche Holding AG (RHHBY)
  • Philip Morris International (PM)
  • Cameco Corporation (CCJ)
  • GW Pharmaceuticals plc (GWPRF)
  • First Mining Finance Corp. (FF.V)
 

Curzio Research publishes market commentary for informational and educational purposes. The opinions expressed and market conditions when the content is published may change. It is not personalized investment advice or an offer to buy or sell securities. Investing involves risk, including possible loss of principal. Do your own research and consult a qualified investment professional before making investment decisions.

Terms of Use | Legal | Privacy Policy

Read the signs. Beat the market.
The market intelligence you need to invest one step ahead. Go beyond the headlines. Invest with an insider’s edge.
More about Podcast

The cooler PCE isn’t the win you might think

The PCE came in cooler than expected—but there's a catch. Plus, what inflation means for the upcoming earnings season… Trump's meeting of AI leaders… Anthropic's S-1 is a joke… And not all upgrades and downgrades are equal.

Political headwinds can’t derail the AI trade

Forget politics: The AI power story is stronger than ever. Plus, breaking down the market volatility… What the PMI means for inflation… A diesel export ban? … BofA's year-end targets… And McDonald's (MCD) bleak Investor Day.

View all →
More from Frank Curzio

The market is facing the perfect storm

The perfect storm to push stocks lower. Plus, how Warsh can help ease market fears… Why hyperscalers need to slow AI spending… JB Hunt (JBHT) just sounded the alarm on energy prices… And why did the Clarity Act fail?

The Fed needs to hike rates by 50 basis points

Why the Fed should raise rates by 50 basis points next week. Plus, rising yields will crush stocks… The coming pullback will be a buying opportunity… Will AI "kill us all"? … And Robinhood's "tokenization" efforts.

Prepare for a 10–20% market pullback

The market could pull back 20% from current levels. Plus, Bessent's bond move… Sectors to buy (and avoid) as long-term rates rise… Offshore oil stocks… How to manage big winners… And one of the best business models in the world.

View all →
Latest episodes
Ep. 1397

This earnings season will wreak havoc on the market

Approach earnings season with caution… and get ready for a pullback over the next 6 months. Plus, an offshore oil play and a power stock to buy… Will AI kill the American dream? … And should investors own index funds?

WATCH NOW
Ep. 1396

The cooler PCE isn’t the win you might think

The PCE came in cooler than expected—but there's a catch. Plus, what inflation means for the upcoming earnings season… Trump's meeting of AI leaders… Anthropic's S-1 is a joke… And not all upgrades and downgrades are equal.

WATCH NOW
Ep. 1395

Can inverse ETFs save you from a pullback?

Do inverse ETFs offer protection during a selloff? Plus, should you buy oil stocks now or wait for a pullback? … 2 power stocks to buy amid AI volatility… And a great trade setup in uranium.

WATCH NOW
Ep. 1394

Political headwinds can’t derail the AI trade

Forget politics: The AI power story is stronger than ever. Plus, breaking down the market volatility… What the PMI means for inflation… A diesel export ban? … BofA's year-end targets… And McDonald's (MCD) bleak Investor Day.

WATCH NOW

Most Popular